Forty years ago the U.S. developed a very successful policy to accelerate the impact of early-stage discovery science, and how its intellectual property could be used to innovate new technologies for society. But recently a price control proposal from Sen. Bernie Sanders (I-Vt.) would roll back two generations of successful policy and implement steps that were proven unsuccessful in the 1990s. The U.S. federal government is the largest global funder of discovery in the sciences. This early-stage funding supports discovery science that looks at ideas too far away from cash flow for the private sector to support. And this support in pre-venture discovery has made the U.S. the envy of th
Hence then, the article about sen sanders price controls on drug innovations repeat a failed strategy was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Sen. Sanders: Price controls on drug innovations repeat a failed strategy )